← Back to catalogue

Estremo

FDA UDI

Class II (US FDA UDI)

by Citieffe

Identity

Trade Name
ESTREMO FDA UDI
Generic Name
Orthopaedic inorganic implant inserter/extractor, reusable FDA UDI
Model / Reference
Impaction bolt, cannulated FDA UDI

Identifiers

Catalog Number
EBA-5317 FDA UDI
Primary DI / UDI-DI
08051739535815 FDA UDI
510(k) Number
K181540 FDA UDI
K183666 FDA UDI
FDA Product Code
HSB FDA UDI
GMDN Term
Orthopaedic inorganic implant inserter/extractor, reusable FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3020 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI
Sterilization Method
Moist Heat or Steam Sterilization FDA UDI

Category: Orthopaedic inorganic implant inserter/extractor, reusable

The ESTREMO device is a hand-held, orthopaedic inorganic implant inserter/extractor designed for the surgical insertion and/or extraction of non-tissue-based implants. It features a one-piece or modular configuration with a region that attaches/fits/locks to part of the implant, typically using a mechanism such as twisting (screwing) or plunger deployment. The device is reusable and can be used in both clinical and research settings.

Similar devices

Also classified as Orthopaedic inorganic implant inserter/extractor, reusable.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Citieffe

Sources (1)

  • FDA UDI 9e2fa711-188c-4dd8-83c1-d02249f90846 36 fields · synced Jul 24, 2026